4-Methoxypent-3-en-2-one, 98%, 250mg

Methyl 2-bromo-4-fluoro-5-nitrobenzoate, 98.0%, 100mg

2-Chloro-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

O-(2-Azido-4,6-O-benzylidene-2-deoxy-alpha-D-galactopyranosyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-threonine tert-Butyl Ester>97.0%(HPLC)100mg

Methyl 4-tert-Butylbenzoate>98.0%(GC)25g

(S)-(+)-PANTOLACTONE, 97.0%, 25g

4,4'-(9H-Fluorene-9,9-diyl)bis(2-methylaniline), 95.0%, 250g

Methyl 2-(bromomethyl)-5-chlorobenzoate, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-1701, L 30 m, Ø-Innen 0,32 mm, Filmd. 0,50 µm, 1 Stück

tert-Butyl 3,6-diazabicyclo[3.1.1]heptane-6-carboxylate hydrochloride, 97%, 100mg

3-Ethoxy-5-fluorobenzyl alcohol, 97.0%, 1g

5-Methoxybenzo[d]oxazol-2(3H)-one, 95%, 100mg

3,5-Dichlorobenzotrifluoride, 97.0%, 25g